Abstract
Introduction
Percutaneous needle biopsy (PNB) is the standard of care for diagnosis of breast lesions. Rates of excisional biopsy for breast diagnosis in North America have been reported at approximately 35 %, although significant regional variation exists. A target rate of PNB for diagnosis of breast abnormalities is needed to facilitate quality improvement. We sought to describe the use of PNB in a referral practice, the clinical scenarios prompting PNB or surgical biopsy (SB), and the accuracy and rate of PNB to inform the ultimate development of a benchmark rate of PNB in breast diagnosis.
Materials and methods
Female patients age 18–90 years, referred to Sunnybrook Health Sciences Centre, a large teaching hospital affiliated with the University of Toronto, with a breast lesion prompting tissue diagnosis with SB and/or PNB between 2002 and 2009 were studied. Each biopsied lesion was characterized by method of biopsy: PNB, SB, or PNB followed by SB. For each lesion, we collected data on patient demographics and breast cancer risk, reason for referral, imaging characteristics (breast imaging-reporting and data system classification, full description, final impression before biopsy), and pathology from each biopsy method. We report concordance between the final impression pre-biopsy and the PNB diagnosis with final surgical diagnosis where applicable.
Results
One thousand and twenty-six lesions were biopsied, 987 (96 %) with PNB. The benign:malignant ratio for the entire cohort was 1.2:1. Final impression was concordant with final pathology in 674/862 (78 %) and PNB diagnosis was concordant with SB pathology in 487/556 (88 %). The reasons for SB without PNB were required pathologic evaluation of the entire lesion (n = 19), patient choice (n = 5), other biopsy technique used (n = 6), technical (n = 4), planned mastectomy (n = 3), and enlarging mass (n = 2). 155/559 (28 %) of lesions without evidence of malignancy on PNB ultimately underwent SB. Papillary lesions and radial scars were more likely to undergo SB with or without prior PNB. Lesions deemed to be suspicious or malignant on final impression were more likely to be excised after a benign diagnosis at PNB.
Conclusion
The vast majority of lesions requiring tissue diagnosis can be accurately diagnosed with PNB. Benchmarks for rates of PNB of 90 % or greater may be considered for performance measurement in appropriate populations.
Similar content being viewed by others
References
Silverstein MJ, Recht A, Lagios MD et al (2009) Special report: consensus conference III. Image-detected breast cancer: state-of-the-art diagnosis and treatment. J Am Coll Surg 209:504–520
National Quality Forum 0221 (2012) Needle biopsy to establish diagnosis of cancer precedes surgical excision/resection. Endorsement Summary: Cancer Measures. April 30, 2015, p 6
American Society of Breast Surgeons PQRS Measures (2015) Preoperative Diagnosis of Breast Cancer. Mastery of Surgery Program
Brenner RJ, Bassett LW, Fajardo LL et al (2001) Stereotactic core-needle breast biopsy: a multi-institutional prospective trial. Radiology 218:866–872
Bruening W, Fontanarosa J, Tipton K, Treadwell JR, Launders J, Schoelles K (2010) Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions. Ann Intern Med 152:238–246
Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881–888
Clarke-Pearson EM, Jacobson AF, Boolbol SK et al (2009) Quality assurance initiative at one institution for minimally invasive breast biopsy as the initial diagnostic technique. J Am Coll Surg 208:75–78
Holloway CM, Gagliardi AR (2009) Percutaneous needle biopsy for breast diagnosis: how do surgeons decide? Ann Surg Oncol 16:1629–1636
Gutwein LG, Ang DN, Liu H et al (2011) Utilization of minimally invasive breast biopsy for the evaluation of suspicious breast lesions. Am J Surg 202:127–132
Pocock B, Taback B, Klein L, Joseph KA, El-Tamer M (2009) Preoperative needle biopsy as a potential quality measure in breast cancer surgery. Ann Surg Oncol 16:1108–1111
Del Turco MR, Ponti A, Bick U et al (2010) Quality indicators in breast cancer care. Eur J Cancer 46:2344–2356
Commission on Cancer, American College of SurgeonsCoC Measures for Quality of Cancer Care (2015) CoC Quality of Care Measures. April 30, 2015
Puglisi F, Zuiani C, Bazzocchi M et al (2003) Role of mammography, ultrasound and large core biopsy in the diagnostic evaluation of papillary breast lesions. Oncology 65:311–315
Muradali D, Kulkarni S (2005) Sonography of the breast: to core or not to core? Can Assoc Radiol J 56:276–288
Wen X, Cheng W (2013) Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors. Ann Surg Oncol 20:94–101
Lannin DR, Ponn T, Andrejeva L, Philpotts L (2006) Should all breast cancers be diagnosed by needle biopsy? Am J Surg 192:450–454
Olaya W, Bae W, Wong J et al (2010) Are percutaneous biopsy rates a reasonable quality measure in breast cancer management? Ann Surg Oncol 17:268–272
Olaya W, Bae W, Wong J et al (2010) Accuracy and upgrade rates of percutaneous breast biopsy: the surgeon’s role. Am Surg 76:1084–1087
Lovrics P, Hodgson N, O’Brien MA et al (2014) Results of a surgeon-directed quality improvement project on breast cancer surgery outcomes in South-Central Ontario. Ann Surg Oncol 21:2181–2187
Breslin TM, Caughran J, Pettinga J et al (2011) Improving breast cancer care through a regional quality collaborative. Surgery 150:635–642
Breast Centres Standards (2014) National Accreditation Program for Breast Centres Standards Manual 1:79
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict to report.
Rights and permissions
About this article
Cite this article
Holloway, C.M.B., Al-Riyees, L. & Saskin, R. Utilization of Percutaneous Needle Biopsy for Breast Diagnosis in a Comprehensive Breast Center: Implications for Development of Quality Indicators. World J Surg 40, 1590–1599 (2016). https://doi.org/10.1007/s00268-015-3293-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-015-3293-0